195 related articles for article (PubMed ID: 16430777)
21. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation.
Troyanovsky B; Levchenko T; Månsson G; Matvijenko O; Holmgren L
J Cell Biol; 2001 Mar; 152(6):1247-54. PubMed ID: 11257124
[TBL] [Abstract][Full Text] [Related]
22. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
23. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mansel RE
Int J Mol Med; 2006 Apr; 17(4):583-90. PubMed ID: 16525713
[TBL] [Abstract][Full Text] [Related]
24. Angiomotin regulates endothelial cell-cell junctions and cell motility.
Bratt A; Birot O; Sinha I; Veitonmäki N; Aase K; Ernkvist M; Holmgren L
J Biol Chem; 2005 Oct; 280(41):34859-69. PubMed ID: 16043488
[TBL] [Abstract][Full Text] [Related]
25. Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors.
Fridman V; Humblet C; Bonjean K; Boniver J
Virchows Arch; 2000 Dec; 437(6):611-7. PubMed ID: 11193472
[TBL] [Abstract][Full Text] [Related]
26. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer.
Lipponen P; Saarelainen E; Ji H; Aaltomaa S; Syrjänen K
J Pathol; 1994 Oct; 174(2):101-9. PubMed ID: 7965405
[TBL] [Abstract][Full Text] [Related]
27. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.
Zhou S; Wang GP; Liu C; Zhou M
BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208
[TBL] [Abstract][Full Text] [Related]
28. E-cadherin as a prognostic indicator in primary breast cancer.
Parker C; Rampaul RS; Pinder SE; Bell JA; Wencyk PM; Blamey RW; Nicholson RI; Robertson JF
Br J Cancer; 2001 Dec; 85(12):1958-63. PubMed ID: 11747340
[TBL] [Abstract][Full Text] [Related]
29. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer.
Van den Eynden GG; Van der Auwera I; Van Laere SJ; Colpaert CG; Turley H; Harris AL; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
Br J Cancer; 2005 Nov; 93(10):1128-36. PubMed ID: 16251878
[TBL] [Abstract][Full Text] [Related]
30. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.
Toi M; Kashitani J; Tominaga T
Int J Cancer; 1993 Sep; 55(3):371-4. PubMed ID: 7690738
[TBL] [Abstract][Full Text] [Related]
31. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
32. Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome.
Goyal A; Martin TA; Mansel RE; Jiang WG
World J Surg Oncol; 2008 Jun; 6():56. PubMed ID: 18547424
[TBL] [Abstract][Full Text] [Related]
33. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.
Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sakurai M; Sowa M
Br J Cancer; 1995 Jun; 71(6):1297-301. PubMed ID: 7779727
[TBL] [Abstract][Full Text] [Related]
34. Angiomotin expression promotes hemangioendothelioma invasion.
Levchenko T; Bratt A; Arbiser JL; Holmgren L
Oncogene; 2004 Feb; 23(7):1469-73. PubMed ID: 14730344
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.
Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C
Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342
[TBL] [Abstract][Full Text] [Related]
36. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
37. Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer.
Davies SR; Watkins G; Mansel RE; Jiang WG
Ann Surg Oncol; 2007 Jun; 14(6):1909-18. PubMed ID: 17406949
[TBL] [Abstract][Full Text] [Related]
38. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
39. Angiomotin p80/p130 ratio: a new indicator of exercise-induced angiogenic activity in skeletal muscles from obese and non-obese rats?
Roudier E; Chapados N; Decary S; Gineste C; Le Bel C; Lavoie JM; Bergeron R; Birot O
J Physiol; 2009 Aug; 587(Pt 16):4105-19. PubMed ID: 19546164
[TBL] [Abstract][Full Text] [Related]
40. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
